chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID-19; She got exposed to COVID-19 and started having symptoms on 30-APR-2023; This spontaneous case was reported by a patient and describes the occurrence of EXPOSURE TO SARS-COV-2 (She got exposed to COVID-19 and started having symptoms on 30-APR-2023) and COVID-19 (COVID-19) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st dose) in March 2021, PFIZER BIONTECH COVID-19 VACCINE (2nd dose) in April 2021, PFIZER BIONTECH COVID-19 VACCINE (1 st booster) in October 2021 and PFIZER BIONTECH COVID-19 VACCINE (2 nd booster). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.   In September 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Apr-2023, received sixth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPOSURE TO SARS-COV-2 (She got exposed to COVID-19 and started having symptoms on 30-APR-2023). On 01-May-2023, the patient experienced COVID-19 (COVID-19). At the time of the report, EXPOSURE TO SARS-COV-2 (She got exposed to COVID-19 and started having symptoms on 30-APR-2023) and COVID-19 (COVID-19) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-May-2023, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. Suspect product dosage text was reported as additional booster. It was reported that patient did not had any adverse event after second bivalent shot but on 27-APR-2023 was got exposed to COVID-19 and started having symptoms on 30-APR-2023,symptoms that were experienced were fatigue, chills coughing, sneezing, nasal drip, partial loss of taste and smell, patient was recovering but was still blowing nose on 08-MAY-2023. No treatment information was provided.
Within 25 mins, I felt knife like pain in my lower back.  It has been there constantly since the injection and pulsate and radiate after 15- 20 mins or if I twist and turn.  If I stretch I feel the pain.  It feels like someone is sticking a knife in my back.
PATIENT COMPLAINED OF FEELING CLAMMY, SLOW PULSE.  DRANK WATER, OBSERVED
20 hours after injection I experienced swelling of both hands as well as very itchy palms.  This lasted 1 hour and subsided on it's own. No intervention.
21Jan98  recv vax. 31Jan98 Pt exp wheezing. Additional info has been required.
Outside of headache and chills, my most concerning symptoms for this reporting were:  1) heart rate increased to 100+ beats per min (typically it is 70 beats per min) 2) veins distended visibly on the side of my forehead (this never happens) 3) 3/31/21-6/10/21 - Onset of extreme fatigue since I received the 2nd dose.   I have a cardiac appointment scheduled 6/28/21.   I have a general physical scheduled 8/12/21.  I will discuss these concerns with both physicians at that time.
No adverse event; 113 Bivalent doses administered after the BUD to patients 12 and up.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) in a 30-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7148B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 03-Nov-2022 at 3:05 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 03-Nov-2022 at 3:05 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (113 Bivalent doses administered after the BUD to patients 12 and up.).    No concomitant drug information was provided.  It was reported that 51 doses from Lot AS7140C, and 60 doses from Lot AS7148B were administered. No treatment drug information was provided.   This case was linked (Patient Link).
pt recv vax 215P 25JUL96; 11PM on 25JUL96 pt exp fever, back pain, arm soreness, h/a;pt was seen in ER;sx have lessened but cont;
Rebound COVID-19 infection 6 days post completion of the complete course of Paxlovid; COVID-19; COVID-19; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient. A 45-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Nov2022 as dose 4 (booster), single (Lot number: GJ6738) at the age of 45 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 07Mar2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 28Mar2021 as dose 2, single (Lot number: EP7534), in right arm and on 01Oct2021 as dose 3 (booster), single (Lot number: FC3181), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Diabetes" (unspecified if ongoing); "Anemia" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Aspirin, reaction: "known allergies: Aspirin"; Ibuprofen, reaction: "known allergies: ibuprofen", notes: known allergies: ibuprofen; Naproxen sodium, reaction: "known allergies: Naproxen Sodium". The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Dec2022, outcome "recovered" and all described as "COVID-19"; DISEASE RECURRENCE (medically significant) with onset 21Dec2022, outcome "recovering", described as "Rebound COVID-19 infection 6 days post completion of the complete course of Paxlovid". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Therapeutic measures were not taken as a result of disease recurrence.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
VOMITING; HEADACHE; NAUSEA; SINUS HEADACHE ACROSS NOSE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 17-MAR-2021, the subject experienced sinus headache. On 17-MAR-2021, the subject experienced nausea. On an unspecified date, the subject experienced vomiting, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, headache, and nausea on 17-MAR-2021, and sinus headache. This report was non-serious.
Swelling of the thigh, temperature starting at 100.5 to 104.1 for the next 80 hours. Not eating, constant Epsom salt baths, cool towels, MOTRIN and TYLENOL switches. Swelling lasted till Friday 11am. Fever finally broke followed by vomiting 2 times. Baby slept continuously.
Sensation of heat and numbness tingling in Chest up into throat mouth and lips, palpitations, dizziness,  elevated heart rate, chills, tingling in extremeties, burning in throat ; started aprroximately two minutes after administration, took benedryl and water, waited another 15 minutes where signs and symptoms started to subside a little bit and thought I was okay but then came back at about 25 minutes post vaccine where it was decided to go to emergency department.
Horrible Pain, Chills, and fever.  Started at 11pm, and restarted at 3 am.  Felt absolutely awful.  Regret taking second shot.  Advising husband to not get.  Still have arm pain from first shot 28 days prior.  Now other arm hurts too
Information has been received from a certified medical assistant (C.M.A.), for the Pregnancy Registry for GARDASIL, concerning a 14 year old female with Ascus positive HR HPV, late care who on 14-AUG-2007 was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL (Lot #657617/0384U), on 15-OCT-2007 was vaccinated intramuscularly with the second 0.5 ml dose of GARDASIL (Lot #657617/0384U) and on 13-MAR-2008 was vaccinated intramuscularly with the third 0.5 ml dose of GARDASIL (Lot #758222/0927U). Concomitant therapy included prenatal vitamins (PVN). There was no concomitant medication. The patient was pregnant, and her last menstrual period was 18-FEB-2008 and the estimated delivery date will be on 17-NOV-2008 (previously reported as 24-NOV-2008). No adverse event was reported. Medical attention was sought via office visit. Follow up information was received which reported that on 02-NOV-2008, the patient delivered a normal and healthy male baby. The patient had complications, she had mild preclampsia and she was scheduled for induction on 31-OCT-2008. The patient underwent CERVIDIL and PITOCIN, the patient failed to dilate past 4 cm. The patient and partner elected for C/section. There was no infections or illness during pregnancy reported. During the pregnancy was used PROCARDIA, 10 mg, every four hours for threatened pre term labor. Upon internal review failed to dilate was considered an other important medical event because the patient required a C-section. Additional information has been requested.
After a brief interval after receiving the shot, I felt queasy and developed a headache.  It was not severe and I drove home.  By the time I arrived home (10 minutes) I felt very tired and went to my room and slept a few hours.  Upon awakening, the headache was gone as was the nausea.  My arm was sore later that night and remained sore for a few days then resolved.  I have also has some lingering fatigue as compared to my normal energy level.  I am not prone to headaches nor do I ever nap so the occurrence of both of these issues right after receiving the shot makes me concerned about a reaction to the reagent or vehicle that delivers the mrna fragment.
passed out; Joint pain; nausea; body aches; i broke into a sweat; feel poorly/ feeling like hit by a truck; tried to stand up; This case was reported by a pharmacist via sales rep and described the occurrence of passed out in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date and did not experience any adverse event ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced passed out (serious criteria GSK medically significant), joint pain, nausea, general body pain, sweating, feeling abnormal and difficulty in standing. On an unknown date, the outcome of the passed out, joint pain, nausea, general body pain, sweating, feeling abnormal and difficulty in standing were recovering/resolving.   It was unknown if the reporter considered the passed out, joint pain, nausea, general body pain, sweating, feeling abnormal and difficulty in standing to be related to Shingrix.  Additional details were provided as follows: The age at vaciantion was not reported. The patient got the Shingrix shot right after lunch and started to feel poorly during the night.  The patient woke up the next day and felt she had been hit by a truck.  She experienced Joint pain, nausea, body aches.  It was reported that when patient was tried to stand up after using the commode, she broke into a sweat and passed out on the bathroom floor.  That first day was the worst. Each day the patient was feeling little better.  The patient was able to leave the house by the fourth day. The case has been linked with the case US2020AMR008685, reported by same reporter.
11:25am Headache 11:37am Patient voiced that she was feeling much better. 160/96, HR 78, O2Sat 95% RM
May have received a third dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 20-FEB-2023 Reporter's Comments: The health care professional reported that he/she had a patient who thought that he may had received a third dose of the Shingrix vaccine by mistake (from different providers) and asked that what precautions should he take. Additional Supportive Information: The patient received the third dose of Shingrix vaccine by mistake, which had led to extra dose administered.
POSITIVE RESULT OF INFLUENZA B; POSITIVE TEST RESULT OF RSV; COLD SYMPTOMS; COUGH; CONGESTION; GREEN MUCUS; A spontaneous report has been received from a health professional. The report concerns a female patient age (4 years, height 108 cm, weight 22 kg).    No medical history was reported. The following demography was reported for the patient's parent:   Sex: Unknown    No concomitant products were reported.    The patient received Flumist Quadrivalent (influenza vaccine live reassort 4v) (batch number PH3533) (expiration date 27-NOV-2022) once/single administration, via nasal route, on 24-OCT-2022.     A unknown administered FLUMIST QUADRIVALENT. No malfunction has been reported for this combination product.    On 28-OCT-2022, the patient experienced cold symptoms (preferred term: Nasopharyngitis), cough (preferred term: Cough), congestion (preferred term: Nasal congestion) and green mucus (preferred term: Secretion discharge). On 02-NOV-2022, the patient experienced positive result of influenza b (preferred term: Influenza B virus test positive) and positive test result of rsv (preferred term: Respiratory syncytial virus test positive).     Treatment with Flumist Quadrivalent (influenza vaccine live reassort 4v) was not changed.     The patient recovered from the event(s) of cold symptoms, cough, congestion and green mucus on an unspecified date. The outcome of the event(s) of positive result of influenza b and positive test result of rsv was unknown.     The events were considered non-serious.     Laboratory values are available.    Device Information:     Combination Product Report: Yes    Product As Reported: FLUMIST QUADRIVALENT  Common Device Name: Nasal Spray  Procode: CCQ  Product Role: Suspect
side effect; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect). At the time of the report, VACCINATION COMPLICATION (side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Several hours after injection - Donor reports dizziness - warmth - flush feeling. Arm began to swell - Red area around injection site. Site warm to touch.
First dose / on Nov 2019 and has not received the second dose yet; This case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in November 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaaccination was not applicable for this report. The patient was past due for dose 2 of Shingrix. Till the time of reporting, the patient did not receive 2nd dose of Shingrix which led to incomplete course of vaccination. The reporter consented to follow up.
seven patients received wrong doses of the Moderna COVID 19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (seven patients received wrong doses of the Moderna COVID 19 vaccine) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007J21-2A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (seven patients received wrong doses of the Moderna COVID 19 vaccine). At the time of the report, ACCIDENTAL OVERDOSE (seven patients received wrong doses of the Moderna COVID 19 vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that five of the seven patients received a 3rd dose instead of the booster dose, while two of the patients received a double dose of the 3rd dose.  No treatment information was reported.
who got the shot got shingles right after; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-FEB-2023  Reporter's comment: This case was reported via interactive digital media. The reporter stated that everyone he/she knew who got the Shingles shot, had got shingles right after, get this off from his/her feed.  Additional Supportive Information: Follow-up would not possible as no contact details were available.
Swelling, patchy redness of entire left arm.  Also area of numbness at place where shot was administered.
My arm has been horribly injured. I think they damaged a nerve and/or bone in my arm. My arm has had severe pain and weakness for more than a month now. I have pain at night in my arm that keeps me up. I cant do the normal things I could do with my arm before this vaccine. Please help me!
Narrative: He reports having developed nausea, diarrhea, and abdominal cramping after the first vaccination. Issues started the day after vaccination and lasted for about 1-2 days. He did not try or apply therapies and was able to tolerate oral intake. No other common adverse effects were  experienced.
So about ten hours after the vaccine, I had a fever and left work not feeling well. I had a fever all day Tuesday and then Wednesday I was nauseas and had muscle pains as well. I have also had sharp pains in my back and shooting into my legs, I cannot get dressed by myself or go to the bathroom. I have not ever had any problems before. It's like a sciatic pain, a back pain. I went to the Dr. Wednesday or Thursday (21st or 22nd of July), I am not sure when. The Dr. can't really do anything for me except take Tylenol. I have an x-ray scheduled, and my next step is Chiropractic work and possibly Physical therapy. I struggle daily just to do my normal daily activities at this point.
MILD COVID-19 INFECTION; This spontaneous report received from a patient via a company representative concerned an 81 year old female. The patient's height, and weight were not reported. The patient's past medical history included: surgery. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On OCT-2021, the patient experienced mild covid-19 infection. On NOV-2021, Laboratory data included: COVID-19 virus test (NR: not provided) positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of mild covid-19 infection was not reported. This report was non-serious. This report was associated with product quality complaint: 90000212541.
Fever. (103) for 3 days  Intense pain in joints.    Strong Headache.  Tinnitus developed and sustained currently.
After receiving the second dose of Pfizer covid 19 vaccine on Monday, February 8,  I did experience muscle aches, low grade fever and headache 24 hrs after the shot. Those symptoms lasted for about 3-4 days. Then on Sunday morning February 14 I work up with sciatic pain on my left leg. Then on Monday February 15 my right eye was red after I woke up that morning. Gradually during the week my eye continued to be red, blurry, and eventually cloudy Friday morning February 19. Found an eye doctor who could see me that morning. He diagnose me having Iritis and prescribed me durezol eye drops. I had to put one drop every 2hr until it gradually got better. I'm still under his care.
Employee called in to advise that her both her eyes were swollen along with her upper arm was swollen where the injection was given. Employee went to an urgent care to be checked and they could not provide a definitive answer that her symptoms were due to the Hepatitis B vaccination she received or due to something else. Employee was prescribed Benadryl.
Pt developed an onset of joint pain right 1st MTP (metatarsal phalangeal), left heel and both elbows 4 days post vax.
After getting vaccinated, I now have joint pain. Primarily in my hands, wrists, hips and legs.
Two days after the vaccine shot the area where it was injected was very swollen and red and very hot to the touch.  I used ice and Benadryl cream per my physician since it had a bit of an itch to it.   It improved over the next week, however, my skin became brown in color and seemed dry.  By the 8th day, the brown area started to peel.  It is like I have a bad sunburn in that one area.  The skin under the skin that peeled off is very pink and delicate and I am scared of infection or a sunbrun.
High heart rate notifications from 11:00 PM until 5:00 AM while I was trying to sleep, as well as chills, fever, and body aches.